Cargando…
Differences in Vitreous Protein Profiles in Patients With Proliferative Diabetic Retinopathy Before and After Ranibizumab Treatment
Proliferative diabetic retinopathy (PDR) accounts for severe impact on vision, its mechanism is still poorly understood. To compare the differences of vitreous protein profiles in PDR patients before and after a complete anti-vascular endothelial growth factor (VEGF) loading dose with ranibizumab tr...
Autores principales: | She, Xinping, Zou, Chen, Zheng, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198965/ https://www.ncbi.nlm.nih.gov/pubmed/35721061 http://dx.doi.org/10.3389/fmed.2022.776855 |
Ejemplares similares
-
Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis
por: Zou, Chen, et al.
Publicado: (2018) -
The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage
por: Li, Shengguo, et al.
Publicado: (2022) -
Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection
por: Zou, Chen, et al.
Publicado: (2018) -
Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy
por: Wu, Guanrong, et al.
Publicado: (2021) -
Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy
por: Wang, Hanying, et al.
Publicado: (2022)